Tadashi Manabe
Tachikawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies.
Journal: Research square
Published: November 24, 2025
Anxiety, depression, and fear after coronavirus disease 2019 infection and their association with long coronavirus disease symptoms.
Journal: Frontiers in psychiatry
Published: July 24, 2025
Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life.
Journal: BMJ open respiratory research
Published: October 05, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
Journal: Nature genetics
Published: June 25, 2023
Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study.
Journal: Respiratory investigation
Published: March 13, 2023
Remodeling of the tumor/tumor microenvironment ecosystem during KRAS G12C inhibitor clinical resistance in lung cancer.
Journal: The Journal of clinical investigation
Published: February 15, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Journal: Nature
Published: October 26, 2021
Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol.
Journal: BMJ open respiratory research
Published: June 10, 2021
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer.
Journal: Cancer research
Published: December 11, 2020
Functional dissection of the KRAS G12C mutation by comparison among multiple oncogenic driver mutations in a lung cancer cell line model.
Journal: Biochemical and biophysical research communications
Published: October 27, 2020
Last Updated: 09/26/2026